What Clinicians Need to Know Now: COVID Toes vs Chilblains
Acral eruptions that look like chilblains can be the first—and sometimes only—clue to SARS-CoV-2 exposure. In 2025, you will still meet patients with chilblain-like lesions where PCR is negative and systemic symptoms are minimal. The clinical task is fast triage: distinguish seasonal perniosis from SARS-CoV-2–associated pernio, rule out dangerous mimics, and decide whether to test, treat, reassure, or refer.
Evidence syntheses show a consistent pattern: young patients, self-limited course, and lesions that behave like perniosis but arise without cold exposure. A practical approach folds in exposure history, timing of testing, nailfold/dermoscopy clues, and selective labs or biopsy. The goal is confident bedside decision-making that avoids unnecessary workups while not missing vasculitis or frostbite.
For background on mechanisms and phenotype, see this concise review of COVID-associated pernio and interferon biology in Mayo Clinic Proceedings. Your bottom line: most cases are benign, but a structured differential protects patients and your schedule.
Bookmark this guide to standardize your documentation and counseling in under three minutes during busy clinics.
Clinical Features Distinguishing COVID Toes from Classic Chilblains
Pattern recognition starts with context and chronology. Classic chilblains follow damp, non-freezing cold; COVID toes often appear out of season or without clear cold exposure. Edematous erythematous–violaceous papules and plaques on toes predominate; finger involvement and periungual changes may occur.
Course helps the call. COVID toes tend to be tender or pruritic with swelling, sometimes blistering, and often resolve over 2–6 weeks; recurrence can track with viral waves rather than weather. Systemic symptoms are usually absent or mild, and many patients recall recent upper-respiratory–type illness in the prior weeks.
Key Differential Diagnosis: Perniosis, Frostbite, Vasculitis, Autoimmune and Hematologic Mimics
Build a deliberate differential to prevent misses. Perniosis (idiopathic or secondary), frostbite, small-vessel vasculitis (including ANCA-associated), chilblain lupus, cryoglobulinemia, cold agglutinin disease, microembolic phenomena, and hematologic disorders can mimic COVID toes.
Red flags for alternative diagnoses include true freezing exposure, digital pallor progressing to necrosis, livedo racemosa, systemic “B symptoms,” neuropathy, or multi-organ signs. Photos plus pulse exam and capillary refill are quick, high-yield additions that sharpen triage.
Pathophysiology Update: SARS-CoV-2 Pernio, Interferon Hypothesis, and Microvascular Injury
Type I interferon signaling likely drives many SARS-CoV-2 pernio cases. Case series demonstrate robust IFN-α responses and lymphocytic vasculitis patterns resembling interferonopathies, aligning with the benign course seen in younger patients.
Microvascular changes—including endothelial activation and occasional fibrin thrombi—have been reported in biopsy studies, supporting a model of immune-triggered microvascular injury rather than direct viral cytopathy in most cases. This helps explain negative PCR at presentation and the self-limited course.
When to Test: COVID Toes PCR vs Antibody vs Antigen—Practical Scenarios
Testing is situational and timing-dependent. PCR and antigen have highest yield in the first several days of respiratory symptoms, but many “COVID toes” appear weeks later when PCR is often negative and antigen is unhelpful. In those later windows, serology may show prior infection but rarely changes management.
Test if results change isolation advice for household contacts, influence access to antivirals in at-risk patients, or are required by public health or employer policy. Otherwise, document suspected post-viral pernio and counsel on supportive care and warning signs.
Bedside Approach: History, Exam, Photodocumentation, and Red Flags for Referral
A 90-second structured history clarifies most cases. Ask about cold/wet exposure, timing vs recent URI, autoimmune history, Raynaud’s, medications, and thrombotic risk. Examine pulses, capillary refill, nailfolds, and perform a quick neurovascular check.
High-quality photos speed dermatology curbside consults and track evolution. Refer urgently if there is progressive ischemia, ulceration with systemic signs, or suspected vasculitis.
- Red flags to escalate: necrosis or rapidly spreading purpura; systemic fever/arthralgia; neuropathic pain; livedo racemosa; abnormal pulses.
Role of Labs, Imaging, Dermoscopy, and Skin Biopsy in Chilblain-like Lesions Differential Diagnosis
Order selective labs—don’t shotgun. CBC, ANA, complements, antiphospholipid antibodies, cryoglobulins (if history suggests), and cold agglutinins can be targeted by history. Dermoscopy may show red-purple dots/clods and reticular patterns that support pernio-like pathology.
Reserve biopsy for atypical, persistent, ulcerative, or diagnostically uncertain cases. Histology typically shows superficial and deep lymphocytic perivascular/perieccrine infiltrates with edema; direct immunofluorescence can be positive.
Management at a Glance: Reassurance vs Treatment for Perniosis, Frostbite, and Vasculitis
Most COVID toes/perniosis need warmth, protection, and time. Counsel on cold avoidance, dry socks, elevation, and analgesics. Consider short courses of topical steroids for itch/burning and nifedipine or pentoxifylline in recurrent or severe perniosis after BP review.
Treat frostbite as a limb-threatening emergency: rapid rewarming, analgesia, blister management, and consideration of thrombolysis/iloprost at specialized centers. Suspected small-vessel vasculitis warrants rheumatology/dermatology referral and systemic workup.
Counseling, Return-to-Activity, and Infection Control Considerations
Counsel that lesions are usually self-limited and non-contagious. Return to daily activity is guided by pain, shoe fit, and skin integrity. Recommend protective footwear and gradual activity ramp when tenderness subsides.
Public-health advice follows unified respiratory virus guidance in the U.S.: stay home while febrile or significantly symptomatic, optimize indoor air, and mask if you must be around others during recovery. Testing is optional when results won’t change behavior or treatment.
Special Populations: Children, Athletes, Raynaud’s/Autoimmune Patients, and the Immunized
Children often present with benign, self-limited courses. Emphasize protection, symptom relief, and watchful waiting unless red flags emerge. Athletes can return as pain allows; protect with wide-toe-box shoes and friction control.
Patients with Raynaud’s or autoimmune disease may flare with cold or illness; coordinate with rheumatology if ulcers, livedo, or systemic features appear. Vaccinated/immunized patients can still develop pernio-like lesions; management remains supportive unless another diagnosis is suspected.
Documentation, Coding, and Follow-up: Closing the Loop in Urgent Care and Primary Care
Write a tight note that future you can trust. Include onset timing, cold exposure, COVID/testing history, distribution, neurovascular status, photos, and safety-net instructions. Reassess in 2–3 weeks or sooner if pain worsens or skin breaks down.
ICD-10-CM options commonly used include T69.1 (chilblains), T33–T34 (frostbite), and L95.x (vasculitis), chosen per final diagnosis. Attach one clear image and add return precautions to close the loop.
Quick Reference Algorithms and Pearls for Busy Clinics
Keep a one-page pathway at your workstation. Step 1: screen for cold exposure and ischemic red flags. Step 2: decide if testing changes management. Step 3: supportive care vs targeted workup. Step 4: follow-up and photos.
Two pearls save time: reassure when the story is classic and stable; escalate early if perfusion is questionable. Standardized photos reduce unnecessary referrals and support curbside consults.
FAQ: Fast answers for busy clinicians
Do COVID toes require isolation? Generally no if the patient feels well and is afebrile; advise standard respiratory virus precautions and staying home while symptomatic per community guidance.
Should I biopsy every case? No. Reserve biopsy for atypical, ulcerative, non-resolving, or systemic cases where results change management.
Which test has the best yield? PCR/antigen only help early in respiratory illness; many COVID-toe presentations are late, so results are often negative and rarely alter care.
When do I start nifedipine? Consider in recurrent or severe perniosis once vascular status and blood pressure permit, after counseling on hypotension and drug interactions.
Print and post your algorithm in triage rooms so nurses and advanced practice providers can align intake questions and photographs with your workflow.
Rapid Takeaways on COVID Toes vs Chilblains
Most chilblain-like lesions in 2025 are self-limited, interferon-pattern eruptions; start with reassurance, exclude ischemia, and test only when it changes care. Use history and seasonality to separate COVID toes from cold-induced perniosis, and watch for vasculitis or frostbite clues.
A focused exam with photos, selective labs, and occasional biopsy provides clarity without over-testing. Clear counseling, return precautions, and precise coding complete safe, efficient care across primary and urgent settings.
